Delving into the Latest Updates on XCEL-UMC-BETA(Syntax for Science) with Synapse

Overview

Basic Info

Drug Type

Mesenchymal stem cell therapy

Synonyms-

Target-

Mechanism

Stem cell replacements

Therapeutic Areas

Nervous System DiseasesOther Diseases

Active Indication-

Inactive Indication

Spinal Cord InjuriesTraumatic spinal cord injury

Originator Organization

Syntax for Science, S.L

Active Organization-

Inactive Organization

Recerca Clinica SLSyntax for Science, S.L

Drug Highest PhasePendingPhase 1/2

First Approval Date-

Regulation-

Login to view timeline

Randomized, double-blind, parallel, two-arms clinical trial to assess the efficacy and safety of 2 infusions of Wharton-Jelly mesenchymal stromal cells (day 1 and day 3, endovenously at 1E6cells/Kg per dose) in patients with moderate acute respiratory distress syndrome (ARDS) secondary to SARS-CoV-2 infection. Follow-up will be established on days 3, 5, 7, 14, 21, and 28. Long term follow-up will be performed at 3, 6 and 12 months.

Start Date13 May 2020

Sponsor / Collaborator

Banc de Sang I Teixits

NCT03003364 / CompletedPhase 1/2IIT

A Phase I/IIa, Randomized, Double-blind, Single-dose, Placebo Controlled, Two-way Crossover Clinical Trial to Assess the Safety and to Obtain Efficacy Data in Intrathecal Administration of Expanded Wharton's Jelly Mesenchymal Stem Cells in Chronic Traumatic Spinal Cord Injury

This is a phase I/IIa, randomized, double-blind, two-arms, two-dose administration, placebo controlled, two-way crossover clinical trial in which 10 patients from 18 to 65 years of age affected with chronic traumatic spinal cord will enter the study with the objective to assess the safety and to obtain efficacy data in intrathecal administration of expanded Wharton's jelly mesenchymal stem cells.

Start Date27 Dec 2016

Sponsor / Collaborator

Banc de Sang I Teixits

[+2]

100 Clinical Results associated with XCEL-UMC-BETA(Syntax for Science)

Login to view more data

100 Translational Medicine associated with XCEL-UMC-BETA(Syntax for Science)

Login to view more data

100 Patents (Medical) associated with XCEL-UMC-BETA(Syntax for Science)

Login to view more data

100 Deals associated with XCEL-UMC-BETA(Syntax for Science)

Login to view more data

R&D Status

10 top R&D records.

Login

to view more data

Indication	Highest Phase	Country/Location	Organization	Date
Spinal Cord Injuries	Phase 2	ES	Syntax for Science, S.L	27 Dec 2016
Spinal Cord Injuries	Phase 2	ES	Recerca Clinica SL	27 Dec 2016
Traumatic spinal cord injury	Phase 2	ES	Syntax for Science, S.L	27 Dec 2016
Traumatic spinal cord injury	Phase 2	ES	Recerca Clinica SL	27 Dec 2016